Prof Charles Swanton at ESMO 2014: The TRACERx study of NSCLC

EMJ has 458 videos Subscribe Here

Description: At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which is a study that defines lung cancer in both space and time through multiregion and longitudinal tumour sampling and genetic analysis.
Shared By : EMJ
Posted on : 03/16/15
Added : 3 years ago


Nothing found.

More From EMJ

Nothing found.